MAGE-A3 immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAGE-A3 immunotherapy, covering 2013-06-24 to 2013-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma [Phase 2, Phase 3]